SCHEMBL1403908

SCHEMBL1403908

CCCCCCN(C)CCCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.57
ALDH1A1 P00352 2/20 0.57
HSD17B10 Q99714 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
TSHR P16473 1/20 0.57
S1PR2 O95136 1/20 0.55
S1PR1 P21453 1/20 0.55
S1PR3 Q99500 1/20 0.55
S1PR5 Q9H228 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.52
DNM1 Q05193 3/20 0.52
GGPS1 O95749 4/20 0.47
KDM5A P29375 2/20 0.46
KDM4C Q9H3R0 2/20 0.46
PHF8 Q9UPP1 1/20 0.46
FDPS P14324 1/20 0.46
AGTR1 P30556 1/20 0.46
OPRM1 P35372 1/20 0.46
PDE3A Q14432 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20756484 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29174000 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7626625 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL27685183 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL10398804 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL1403868 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL23016786 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL4880552 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL28919673 0.98 LMNA (0.55) LMNAALDH1A1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL28287185 0.98 LMNA (0.55) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399409-B1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF SE (DE) 2012-10-31 EP claimed
CN-100349851-C Method for producing acrylic acid esters BASF AG (DE) 2007-11-21 CN claimed
CN-100349854-C Method for producing (meth) acrylic acid esters BASF AG (DE) 2007-11-21 CN claimed
US-7268251-B2 Method for producing (meth) acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2007-09-11 US claimed
US-7026503-B2 Method for producing (meth)acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2006-04-11 US claimed
EP-1399408-B1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF AG (DE) 2006-03-22 EP claimed
US-20230320995-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES CAPSTAN THERAPEUTICS, INC. (US) 2023-10-12 US disclosed
US-10174349-B2 Recombinant cell producing 2-hydroxyisobutyric acid EVONIK ROEHM GMBH (DE) 2019-01-08 US disclosed
EP-2291530-B1 RECOMBINANT CELL PRODUCING 2-HYDROXYISOBUTYRIC ACID EVONIK ROEHM GMBH (DE) 2018-12-26 EP disclosed
CN-107083352-A Produce the recombinant cell of 2 hydroxy-iso-butyric acids 赢创罗姆有限公司 2017-08-22 CN disclosed
WO-2017032699-A1 METHOD FOR PRODUCING LOW-BOILING (METH)ACRYLIC ACID ESTERS BASF SE (DE) 2017-03-02 WO disclosed
EP-2784059-B1 Method for isolating tertiary amino alcohol TOSHIBA KK (JP) 2016-08-24 EP disclosed
US-9181174-B2 Method for isolating tertiary amino alcohol KABUSHIKI KAISHA TOSHIBA (JP) 2015-11-10 US disclosed
WO-2009156214-A1 RECOMBINANT CELL PRODUCING 2-HYDROXYISOBUTYRIC ACID EVONIK RÖHM GMBH (DE) 2009-12-30 WO disclosed
EP-2125771-A1 PROCESS FOR PREPARING TETRAMETHYL GLYCOLIDE Evonik Röhm GmbH (DE) 2009-12-02 EP disclosed
EP-2091906-A1 PROCESS FOR PREPARING (METH)ACRYLIC ACID Evonik Röhm GmbH (DE) 2009-08-26 EP disclosed
WO-2008061819-A1 PROCESS FOR PREPARING (METH)ACRYLIC ACID EVONIK RÖHM GMBH (DE) 2008-05-29 WO disclosed
WO-2008061821-A1 PROCESS FOR PREPARING TETRAMETHYL GLYCOLIDE EVONIK RÖHM GMBH (DE) 2008-05-29 WO disclosed
CN-101186568-A Process for preparing (meth)acrylic acid EVONIK ROEHM GMBH (DE) 2008-05-28 CN disclosed
CN-101186603-A Process for preparing tetramethyl glycolide EVONIK ROEHM GMBH (DE) 2008-05-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320995-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES PLTP, LNPEP, PLIN3 LMNA 41/4885ALDH1A1 4315/4885HSD17B10 3116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.